drugset / Trial / NCT05135182

Helicobacter Pylori Rescue Treatment in Patients Allergic to Penicillin

NCT05135182

Phase 4 Unknown 170 enrolled Shandong University
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess and compare the effectiveness of furazolidone-tetracycline-containing and metronidazole-tetracycline-containing quadruple regimens for the rescue treatment of Helicobacter pylori infection inpatients allergic to penicillin.

Timeline

Start
2021-11-28
Primary completion
2022-10
Completion
2022-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Furazolidone Small molecule 100 mg Oral
Comparator Metronidazole Small molecule 400 mg Oral